Related references
Note: Only part of the references are listed.Identification of the orphan GPCR, P2Y10 receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor
Masanori Murakami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth
Sandra M. Pasternack et al.
NATURE GENETICS (2008)
The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor
Ken-Ichi Tabata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor, suppressor in A549 lung carcinoma cells
Mandi M. Murph et al.
MOLECULAR CANCER RESEARCH (2007)
Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid
Ayako Uchiyama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Of spiders and crabs: The emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer
Mandi Murph et al.
CLINICAL CANCER RESEARCH (2006)
Homo- and hetero-dimerization of LPA/S1P receptors, OGR1 and GPR4
Alexander Zaslavsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5
Chang-Wook Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo
Kwan-Sik Kim et al.
CANCER RESEARCH (2006)
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis
Daniel L. Baker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes
Knut Kotarsky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
Ahmed Boucharaba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells
J Ren et al.
CANCER RESEARCH (2006)
Lysophosphatidic acid is a major regulator of growth-regulated oncogene α in ovarian cancer.
Z Lee et al.
CANCER RESEARCH (2006)
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells
J Symowicz et al.
CANCER RESEARCH (2005)
Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1
K Hama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lysophosphatidic acid induces neointima formation through PPARγ activation
CX Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells
XJ Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)
MC Huang et al.
ONCOGENE (2004)
Mechanisms of lysophosphatidic acid production
J Aoki
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Lysophosphatidic acid production and action: Validated targets in cancer?
M Umezu-Goto et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer
DN Brindley
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The ins and outs of lysophosphatidic acid signaling
WH Moolenaar et al.
BIOESSAYS (2004)
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
A Boucharaba et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer
D Shida et al.
LABORATORY INVESTIGATION (2004)
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
J Kitayama et al.
BREAST CANCER RESEARCH (2004)
Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells
C Luquain et al.
JOURNAL OF LIPID RESEARCH (2003)
The emerging role of lysophosphatidic acid in cancer
GB Mills et al.
NATURE REVIEWS CANCER (2003)
Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family
K Noguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of an intracellular receptor for lysophosphatidic acid (LPA):: LPA is a transcellular PPARγ agonist
TM McIntyre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1
FN van Leeuwen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Targeted therapy for epithelial ovarian cancer: Current status and future prospects
HT See et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
M Umezu-Goto et al.
JOURNAL OF CELL BIOLOGY (2002)
Lysophosphatidic acid is a bioactive mediator in ovarian cancer
XJ Fang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Avidin-dendrimer-(1B4M-Gd)254:: A tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI
H Kobayashi et al.
BIOCONJUGATE CHEMISTRY (2001)
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells
YL Hu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Lysophospholipids increase interleukin-8 expression in ovarian cancer cells
BM Schwartz et al.
GYNECOLOGIC ONCOLOGY (2001)
The mouse lpA3/Edg7 lysophosphatidic acid receptor gene:: genomic structure, chromosomal localization, and expression pattern
JJA Contos et al.
GENE (2001)
Sphingosine 1-phosphate receptors
T Hla
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2001)
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species - Structure-activity relationship of cloned LPA receptors
K Bandoh et al.
FEBS LETTERS (2000)
Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
RT Penson et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2000)
Share Paper
